Written question asked by Lord Bethell (Conservative) on Monday, 10 February 2025, in the House of Lords. It was due for an answer on Monday, 24 February 2025. It was answered by Baroness Merron (Labour) on Monday, 24 February 2025 on behalf of the Department of Health and Social Care.
Vaccination
- Question
-
To ask His Majesty's Government what plans they have to evolve the Joint Committee on Vaccination and Immunisation's methods to assess the broader socio-economic benefits of vaccination.
- Answer
-
As an independent Departmental Expert Committee, the Joint Committee on Vaccination and Immunisation (JCVI) advises the Department on matters related to vaccination and immunisation. The JCVI bases its advice and recommendations on evidence of the burden of disease, of vaccine safety and efficacy, and of the impact and cost effectiveness of immunisation strategies.
Broader socio-economic factors, such as productivity costs from illness, improved educational attainment from reduced school absences, and out-of-pocket expenses and opportunity costs from attending a vaccination, are not included in the cost-effective analysis which is presented to the JCVI for its consideration. However, these impacts may be highlighted by the JCVI to inform policy-making.
Secondary information
- Type
- Written question
- Reference
- HL4869
- Session
- 2024-26
- Subjects
- Vaccination Joint Committee on Vaccination and Immunisation
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 17:56:46 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL4869
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL4869
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL4869